183 related articles for article (PubMed ID: 7913562)
41. [Humoral mechanisms of in vitro inhibition of mouse lymphocyte immunoreactivity by mastocytoma P815 cells].
Medvedev AE
Biull Eksp Biol Med; 1988 Jun; 105(6):701-3. PubMed ID: 2968820
[TBL] [Abstract][Full Text] [Related]
42. Efferent blockade of delayed-type hypersensitivity responses in the anterior chamber of the eye.
Niederkorn JY; Benson JL; Mayhew E
Reg Immunol; 1990-1991; 3(6):349-54. PubMed ID: 2132760
[TBL] [Abstract][Full Text] [Related]
43. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. III. Morphometric assessment of the dynamic changes in post-capillary venules as regulatory elements of lymphocyte recirculation in tumor-draining lymph nodes.
Tosi P; Syrjänen K; Cintorino M; Mäntyjärvi R; Luzi P; Miracco C; Laatikainen A; Leoncini L; Santopietro R
Arch Geschwulstforsch; 1987; 57(1):7-15. PubMed ID: 3105513
[TBL] [Abstract][Full Text] [Related]
44. Anti-tumor effects of depleting and non-depleting anti-CD27 monoclonal antibodies in immune-competent mice.
Sakanishi T; Yagita H
Biochem Biophys Res Commun; 2010 Mar; 393(4):829-35. PubMed ID: 20171165
[TBL] [Abstract][Full Text] [Related]
45. Activity of tumor-associated lymphoid cells at short intervals after administration of irradiated syngeneic and allogeneic tumor cells.
Schick B; Berke G
J Immunol; 1977 Mar; 118(3):986-91. PubMed ID: 321684
[TBL] [Abstract][Full Text] [Related]
46. Monoclonal antibodies in human organ transplantation and auto-immune diseases.
Wijdenes J; Roy C; Morel-Fourrier B; Racadot E
Therapie; 1992; 47(4):283-7. PubMed ID: 1494788
[TBL] [Abstract][Full Text] [Related]
47. Deviant immune responses to allogeneic tumors injected intracamerally and subcutaneously in mice.
Niederkorn J; Streilein JW; Shadduck JA
Invest Ophthalmol Vis Sci; 1981 Mar; 20(3):355-63. PubMed ID: 6782034
[TBL] [Abstract][Full Text] [Related]
48. The role of CD8+ and CD4+ cells in islet allograft rejection.
Yamamoto H; Monden M; Kawai M; Uenaka A; Gotoh M; Mori T; Sakurai M; Shiku H; Nakayama E
Transplantation; 1990 Jul; 50(1):120-5. PubMed ID: 1973311
[TBL] [Abstract][Full Text] [Related]
49. Helper cells active in the generation of cytotoxicity to a syngeneic tumor.
Hancock EJ; Kilburn DG; Levy JG
J Immunol; 1981 Oct; 127(4):1394-7. PubMed ID: 6168688
[TBL] [Abstract][Full Text] [Related]
50. The antimetastatic function of concomitant antitumor immunity. I. Host Ly-1+2+ effector T cells prevent the enumeration of metastatic tumor cells in a biological assay.
Dye SE
J Immunol; 1986 Feb; 136(4):1504-9. PubMed ID: 3080525
[TBL] [Abstract][Full Text] [Related]
51. In vivo and in vitro antitumor activity expressed by cells of concomitantly immune mice.
Tuttle RL; Knick VC; Stopford CR; Wolberg G
Cancer Res; 1983 Jun; 43(6):2600-5. PubMed ID: 6133611
[TBL] [Abstract][Full Text] [Related]
52. Tryptophan degradation in transplanted tumor cells undergoing rejection.
Yoshida R; Park SW; Yasui H; Takikawa O
J Immunol; 1988 Oct; 141(8):2819-23. PubMed ID: 3262668
[TBL] [Abstract][Full Text] [Related]
53. Characterization of a monoclonal antibody directed to a T cell suppressor factor.
Maier T; Stammers AT; Levy JG
J Immunol; 1983 Oct; 131(4):1843-8. PubMed ID: 6413579
[TBL] [Abstract][Full Text] [Related]
54. Histopathologic analysis of intraocular allogeneic tumors in mice.
Luckenbach MW; Streilein JW; Niederkorn JY
Invest Ophthalmol Vis Sci; 1985 Oct; 26(10):1368-76. PubMed ID: 3930419
[TBL] [Abstract][Full Text] [Related]
55. The effect of anti-L3T4 monoclonal antibody treatment on first-set rejection of murine cardiac allografts.
Madsen JC; Peugh WN; Wood KJ; Morris PJ
Transplantation; 1987 Dec; 44(6):849-52. PubMed ID: 3321596
[No Abstract] [Full Text] [Related]
56. CD4 monoclonal antibody VIT4 in human alloimmune response in vitro and in vivo.
Nachbaur D; Niederwieser D; Aichinger G; Aulitzky W; Tilg H; Eibl B; König P; Gattringer C; Majdic O; Stockinger H; Margreiter R; Oberhuber G; Födinger AM; Schwaighofer H; Huber C
Immunobiology; 1996 Jan; 195(1):33-46. PubMed ID: 8852599
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of graft rejection by LPS: further evidence for effects on T lymphocytes.
Winchurch RA; Hilberg C; Birmingham W; Munster AM
J Reticuloendothel Soc; 1982 Jan; 31(1):31-42. PubMed ID: 6977643
[TBL] [Abstract][Full Text] [Related]
58. Targeting an anti-viral CD8+ T cell response to a growing tumor facilitates its rejection.
Böhm W; Schirmbeck R; Reimann J
Cancer Immunol Immunother; 1997 Jun; 44(4):230-8. PubMed ID: 9222282
[TBL] [Abstract][Full Text] [Related]
59. Human renal allograft and peripheral blood T lymphocyte subpopulations during the onset and treatment of rejection.
Taube D; Welsh K; Hobby P; Williams DG
Clin Nephrol; 1984 Sep; 22(3):127-32. PubMed ID: 6237816
[TBL] [Abstract][Full Text] [Related]
60. Adoptive transfer of immunity to intraocular tumors in mice.
Niederkorn JY; Streilein JW
Invest Ophthalmol Vis Sci; 1984 Mar; 25(3):336-42. PubMed ID: 6421767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
